Form 8-K - Current report:
SEC Accession No. 0001104659-23-033314
Filing Date
2023-03-16
Accepted
2023-03-16 16:10:51
Documents
16
Period of Report
2023-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm239782d1_8k.htm   iXBRL 8-K 37735
2 EXHIBIT 3.1 tm239782d1_ex3-1.htm EX-3.1 6039
3 EXHIBIT 10.1 tm239782d1_ex10-1.htm EX-10.1 25105
4 EXHIBIT 99.1 tm239782d1_ex99-1.htm EX-99.1 11163
8 GRAPHIC tm239782d1_ex99-1img001.jpg GRAPHIC 3407
  Complete submission text file 0001104659-23-033314.txt   275345

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA lptx-20230316.xsd EX-101.SCH 3027
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20230316_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20230316_pre.xml EX-101.PRE 22591
10 EXTRACTED XBRL INSTANCE DOCUMENT tm239782d1_8k_htm.xml XML 3711
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 23738878
SIC: 2834 Pharmaceutical Preparations